Innovation & Emerging Technology, Clinical Outcomes & Patient Safety, Education & Training
KARL STORZ, a family-owned company founded in Tuttlingen (Germany) in 1945, is a globally recognized market leader and solution provider in endoscopy for human and veterinary medicine. With its innovative endoscopes, instruments, units, services, and integrated solutions, KARL STORZ has stood for reliability, quality, and availability for over 75 years. Its portfolio of endoscopic instruments includes more than 15,000 products. In dialog with medical professionals, KARL STORZ shapes and defines medical progress. Innovation, precision, and creativity are the hallmarks of KARL STORZ’s work. The company combines stability with flexibility, anticipating the future while remaining grounded in tradition.
From its headquarters in Tuttlingen, KARL STORZ has grown from a two-person company into a global corporation that now employs 8,500 people at over 50 subsidiaries and is represented in more than 40 countries.
Contact: surgery@karlstorz.com
London CRS returns in 2022 with a top-notch faculty from around the globe showcasing the latest innovative technologies in Digital Surgery. This is a 2- part event, including Advanced Tools and Imaging with a lively discussion between our diverse panelists. Leading surgeons and researchers will describe cutting-edge techniques and provide their personal insights on the future of surgery. Don't miss one of the highlights of the surgical calendar - LondonCRS22! PROGRAM Welcome & Introduction - Dr. Manish Chand and Dr. Steven D. Wexner (USA) 3D Imaging Support – Dr. Salvador Morales-Conde (Spain) Analyzing Surgeon Performance and Automated Tools – Dr. Debby Keller (USA) Intraoperative Decision Support – Dr. OZ Meireles (USA) Using AI to Standardize Fluorescence – Dr. Ronan Cahill (Ireland) Advanced imaging in Surgery – Dr. Alex Vahrmeijer (Netherlands) Discussion – All faculty moderated by Dr. Manish Chand (UK)
Published
Apr 2022
LondonCRS returns in 2022 with a blockbuster faculty from around the globe showcasing the latest innovative technologies in Digital Surgery. This is a 2-part event including Advanced Tools and Imaging with lively discussion between our diverse panelists. Leading surgeons and researchers will describe cutting edge techniques and provide their personal insights on the future of surgery. Don't miss one of the highlights of the surgical calendar - LondonCRS22! PROGRAM Welcome & Introduction - Dr. Manish Chand, Dr. Antonio Lacy (Spain) and Dr. Steven D. Wexner (USA) Pushing the boundaries of endoscopy - Dr. Silvana Perretta (France) Fluorescence and beyond - Dr. Luigi Boni (Italy) Radioisotope imaging in laparoscopy and robotics - Dr. Manish Chand (UK) The rise of the robots - Dr. Venky Munikrishnan (India) Developing Clinical Insights through Augmented Intelligence in Robotic Surgery - Dr. Amit Trivedi (USA) Telementoring in Surgery - Dr. Antonio M. Lacy (Spain) Discussion - All faculty moderated by Dr. Manish Chand (UK)
Published
Apr 2022
Laparoscopic cholecystectomy has gone through massive changes since the approach was first created in 1985. Just to put it in figures, 750,000 laparoscopic cholecystectomy procedures are performed every year in the USA. Dr. Dip discusses an important paper stating that more than 253 laparoscopic bile duct injuries were recorded in 2003. 97% of these injuries were due to the surgeon's visual misperception and the other 3% to defective technical skills. Fluorescence-guided surgery is a very useful emerging technology. The tools required to perform this type of surgery include a light source, a structure, a dye, and a specific camera. The specific dye is Indocyanine Green, which was developed in WWII, which is not metabolized by the human body. The talk focuses on his paper on visualization in different cases where the technique is applied. He discusses a study aimed at establishing whether NIFC (Near-infrared Incisionless Fluorescent) is superior to standard white light when identifying extrahepatic biliary structures. The main conclusion is that NIFC markedly and significantly increased the detection of all extrahepatic biliary structures before and after gallbladder dissection.
Published
Mar 2022
When it comes to the future of surgery, many doctors say that it will be based on Artificial Intelligence, robots, and image-guided surgery. Image-guided surgery can be based on fluorescence imaging but also on tridimensional models. ICG has shown excellent outcomes for bowel perfusion, to identify ureter, and for oncologic surgery. It is used to identify tumors and to identify carcinomatosis, although the study will be focused on gastric cancer. Firstly, let’s identify the pathology that must be treated. Gastric cancer survival is related to the number of lymph nodes removed, which is why the standard care is to perform a lymphadenectomy. The high lymph node ratio is associated with better survival but this high extended lymphadenectomy will mean higher morbidity. Then, ICG can be used in gastric cancer as a lymphatic mapping and to identify the sentinel node. Sentinel node basin dissection avoids recurrence after a false-negative SN biopsy and has a high rate of success. Dr. Morales-Conde compares ICG to two other methods, Blue Dye and Radiocolloid. The main advantage of using ICG over Radiocolloid is that sensibility is higher, there is no radioactivity, and it can detect under fat tissue. It also is important that signal stability is higher and the quantitative assessment. Last but not least, it is the only one that can be used in laparoscopic surgeries. The conclusions are that with ICG a higher number of lymph nodes is obtained and there are no differences in terms of complications.
Published
Mar 2022
Bariatric Surgery
General Surgery
Bariatric Surgery
General Surgery
General Surgery
Bariatric Surgery
Vascular Surgery
Share it with your network and help spread clinical knowledge.
